Fresenius Medical Care AG & Co. KGaA (FMS) 의 후행 P/E는 11.7, 선행 P/E 11.2. 후행 이익수익률은 8.58%, 선행 이익수익률 8.90%. PEG 0.14 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $31.01.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 68/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 20.8 | 1.09 | 2.46 | 1.44 | 1.07% |
| 2017 | 21.0 | 1.82 | 2.73 | 1.51 | 1.10% |
| 2018 | 8.8 | 0.16 | 1.48 | 1.05 | 1.87% |
| 2019 | 24.3 | -0.42 | 2.44 | 1.67 | 1.22% |
| 2020 | 25.9 | -8.75 | 2.69 | 1.69 | 1.16% |
| 2021 | 34.5 | -0.94 | 2.63 | 1.90 | 1.17% |
| 2022 | 26.6 | -0.87 | 1.28 | 0.92 | 2.21% |
| 2023 | 22.6 | 0.47 | 0.83 | 0.58 | 2.91% |
| 2024 | 23.9 | 3.12 | 0.88 | 0.66 | 2.72% |
| 2025 | 12.1 | 0.14 | 0.83 | 0.60 | 3.44% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $1.87 | $17.03B | $1.18B | 6.9% |
| 2017 | $2.08 | $17.78B | $1.28B | 7.2% |
| 2018 | $3.23 | $16.55B | $1.98B | 12% |
| 2019 | $1.98 | $17.48B | $1.2B | 6.9% |
| 2020 | $1.98 | $17.86B | $1.16B | 6.5% |
| 2021 | $1.66 | $17.62B | $969.31M | 5.5% |
| 2022 | $1.15 | $19.4B | $673.41M | 3.5% |
| 2023 | $0.85 | $19.45B | $499M | 2.6% |
| 2024 | $0.92 | $19.34B | $537.91M | 2.8% |
| 2025 | $1.68 | $19.63B | $978M | 5% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $2.06 | $1.76 – $2.31 | $19.64B | $19.58B – $19.68B | 6 |
| 2027 | $2.24 | $2.01 – $2.64 | $20.29B | $20.02B – $20.7B | 5 |
| 2028 | $2.53 | $2.48 – $2.66 | $20.99B | $20.62B – $21.82B | 2 |
| 2029 | $2.95 | $2.89 – $3.11 | $21.91B | $21.51B – $22.77B | 1 |
| 2030 | $3.26 | $3.19 – $3.43 | $22.84B | $22.44B – $23.75B | 1 |
